Jurij Trontelj
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jurij Trontelj has a total of 143 co-authors. Here are the top co-authors by number of shared publications:
- Robert Roškar
Faculty of Pharmacy, University of Ljubljana, Aškerčeva cesta 7, 1000 Ljubljana, Slovenia
6 shared publications Aleš Mrhar
University of Ljubljana , Faculty of Pharmacy Ljubljana , Slovenia
5 shared publicationsRobert Roškar
Faculty of Pharmacy, University of Ljubljana, Aškerčeva cesta 7, 1000 Ljubljana, Slovenia
5 shared publicationsAlbin Kristl
University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia
3 shared publications- Andrej Grobin
University of Ljubljana, Faculty of Pharmacy, Aškerčeva cesta 7, 1000 Ljubljana, Slovenia
3 shared publications - Iztok Grabnar
Faculty of Pharmacy, University of Ljubljana, 1000 Ljubljana, Slovenia
3 shared publications
Latest Publications
- Open Access
- 31 January 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (2) , 329
Development, Fabrication and Application of a Sectioned 3D-Printed Human Nasal Cavity Model for In Vitro Nasal Spray Deposition Studies
In vitro models of the human nasal cavity are crucial for understanding the deposition dynamics of nasally administered drugs. Three-dimensional (3D) printing offers a powerful method for creating patient-specific, anatomically precise models for such experimental purposes. Background/Objectives: This study details the complete workflow for the development, design, and fabrication of a sectioned nasal cavity model intended for droplet deposition analysis of nasal sprays. Methods: A digital nasal cavity model was derived from medical imaging data and optimized for computer-aided design (CAD) operations. It was segmented into five therapeutically relevant regions: nasal vestibule, olfactory area, middle and upper turbinates, lower turbinate, and nasopharynx. Sections were 3D-printed in polypropylene for chemical compatibility, and a carbon fiber-reinforced fixation frame ensured precise alignment and airtight assembly. Results: Functional validation confirmed the model’s functional relevance through comparative deposition studies using automated actuation and high-performance liquid chromatography (HPLC) based regional quantification. Two devices with distinct spray characteristics (characterized separately by laser diffraction, plume geometry, and spray pattern imaging) were tested under varied administration conditions. The study demonstrated the model’s ability to discriminate between products, establishing a solid foundation for future investigations incorporating additional variables. Conclusions: Overall, the developed methodology provides a cost-effective and replicable platform for producing anatomically accurate, sectioned nasal cavity models. The newly developed in vitro system is well suited for detailed, region-specific analysis of nasal spray deposition, offering a valuable tool for pharmaceutical research and development.
- 31 January 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (2) , 329
Open AccessDevelopment, Fabrication and Application of a Sectioned 3D-Printed Human Nasal Cavity Model for In Vitro Nasal Spray Deposition Studies
In vitro models of the human nasal cavity are crucial for understanding the deposition dynamics of nasally administered drugs. Three-dimensional (3D) printing offers a powerful method for creating patient-specific, anatomically precise models for such experimental purposes. Background/Objectives: This study details the complete workflow for the development, design, and fabrication of a sectioned nasal cavity model intended for droplet deposition analysis of nasal sprays. Methods: A digital nasal cavity model was derived from medical imaging data and optimized for computer-aided design (CAD) operations. It was segmented into five therapeutically relevant regions: nasal vestibule, olfactory area, middle and upper turbinates, lower turbinate, and nasopharynx. Sections were 3D-printed in polypropylene for chemical compatibility, and a carbon fiber-reinforced fixation frame ensured precise alignment and airtight assembly. Results: Functional validation confirmed the model’s functional relevance through comparative deposition studies using automated actuation and high-performance liquid chromatography (HPLC) based regional quantification. Two devices with distinct spray characteristics (characterized separately by laser diffraction, plume geometry, and spray pattern imaging) were tested under varied administration conditions. The study demonstrated the model’s ability to discriminate between products, establishing a solid foundation for future investigations incorporating additional variables. Conclusions: Overall, the developed methodology provides a cost-effective and replicable platform for producing anatomically accurate, sectioned nasal cavity models. The newly developed in vitro system is well suited for detailed, region-specific analysis of nasal spray deposition, offering a valuable tool for pharmaceutical research and development.
- Open Access
- 2 October 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 304, 119143
The first subacute study with oral administration of bisphenol AP in male rats: Cardiovascular data and metabolite detection
- 2 October 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 304, 119143
Open AccessThe first subacute study with oral administration of bisphenol AP in male rats: Cardiovascular data and metabolite detection
- Open Access
- 16 October 2024
- Published by Elsevier in Ultrasonics Sonochemistry
- Vol. 111, 107110
Proof-of-concept for removing micropollutants through a combination of sub-atmospheric-pressure non-thermal plasma and hydrodynamic (super)cavitation
- 16 October 2024
- Published by Elsevier in Ultrasonics Sonochemistry
- Vol. 111, 107110
Open AccessProof-of-concept for removing micropollutants through a combination of sub-atmospheric-pressure non-thermal plasma and hydrodynamic (super)cavitation
- Open Access
N-Acetylcysteine Ineffective in Alleviating Hangover from Binge Drinking: A Clinical Study
Alcohol hangover (veisalgia) is a fairly common phenomenon. The pathogenesis of veisalgia is not understood and treatment has not yet been established. Occasionally, students take N-acetylcysteine (NAC) before binge drinking to alleviate hangover. The aim of this study was to evaluate the effect of NAC on serum levels of electrolytes, enzymes, oxidative stress biomarkers and symptoms of veisalgia in binge drinking. In this randomized, double-blind, placebo-controlled study, healthy students were randomly assigned into two groups: one receiving NAC and the other receiving a placebo. Blood samples were taken before drinking, 30 min after a 1.5 h long drinking session, and the subsequent morning. Serum levels of electrolytes, urea, enzymes, ethanol, 8-Hydroxydeoxyguanosine (8-OHdG) and N-epsilon-hexanoyl-lysine were measured. The participants completed the Acute Hangover Severity Scale (AHSS) assessment based on symptoms, and 40 students (20 male), aged 23 ± 2 years, were included in the study. Their mean blood ethanol concentration was 1.4 g/kg. Serum sodium levels were increased after drinking, and urea decreased the following morning compared to their levels before drinking in both groups. Serum 8-OHdG levels were increased after drinking and remained elevated until the following morning, compared to the levels before drinking, in both groups. NAC had no effect on sodium, urea and 8-OHdG levels or the symptoms of veisalgia. In conclusion, binge drinking causes a transient increase in serum sodium and as a prolonged increase in oxidative marker 8-OHdG levels. NAC had no effect on the sodium and 8-OHdG levels.
Open AccessN-Acetylcysteine Ineffective in Alleviating Hangover from Binge Drinking: A Clinical Study
Alcohol hangover (veisalgia) is a fairly common phenomenon. The pathogenesis of veisalgia is not understood and treatment has not yet been established. Occasionally, students take N-acetylcysteine (NAC) before binge drinking to alleviate hangover. The aim of this study was to evaluate the effect of NAC on serum levels of electrolytes, enzymes, oxidative stress biomarkers and symptoms of veisalgia in binge drinking. In this randomized, double-blind, placebo-controlled study, healthy students were randomly assigned into two groups: one receiving NAC and the other receiving a placebo. Blood samples were taken before drinking, 30 min after a 1.5 h long drinking session, and the subsequent morning. Serum levels of electrolytes, urea, enzymes, ethanol, 8-Hydroxydeoxyguanosine (8-OHdG) and N-epsilon-hexanoyl-lysine were measured. The participants completed the Acute Hangover Severity Scale (AHSS) assessment based on symptoms, and 40 students (20 male), aged 23 ± 2 years, were included in the study. Their mean blood ethanol concentration was 1.4 g/kg. Serum sodium levels were increased after drinking, and urea decreased the following morning compared to their levels before drinking in both groups. Serum 8-OHdG levels were increased after drinking and remained elevated until the following morning, compared to the levels before drinking, in both groups. NAC had no effect on sodium, urea and 8-OHdG levels or the symptoms of veisalgia. In conclusion, binge drinking causes a transient increase in serum sodium and as a prolonged increase in oxidative marker 8-OHdG levels. NAC had no effect on the sodium and 8-OHdG levels.
- Open Access
- 3 August 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (8) , 1040
Application of a Novel Dissolution Medium with Lipids for In Vitro Simulation of the Postprandial Gastric Content
Food can change various physiological parameters along the gastrointestinal tract, potentially impacting postprandial drug absorption. It is thus important to consider different in vivo conditions during in vitro studies. Therefore, a novel dissolution medium simulating variable postprandial pH values and lipid concentrations was developed and used in this study. Additionally, by establishing and validating a suitable analytical method, the effects of these parameters on the dissolution of a model drug, cinnarizine, and on its distribution between the lipid and aqueous phases of the medium were studied. Both parameters, pH value and lipid concentration, were shown to influence cinnarizine behavior in the in vitro dissolution studies. The amount of dissolved drug decreased with increasing pH due to cinnarizine’s decreasing solubility. At pH values 5 and 7, the higher concentration of lipids in the medium increased drug dissolution, and most of the dissolved drug was distributed in the lipid phase. In all media with a lower pH of 3, dissolution was fast and complete, with a significant amount of drug distributed in the lipid phase. These results are in accordance with the in vivo observed positive food effect on cinnarizine bioavailability described in the literature. The developed medium, with its ability to easily adjust the pH level and lipid concentration, thus offers a promising tool for assessing the effect of co-ingested food on the dissolution kinetics of poorly soluble drugs.
- 3 August 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (8) , 1040
Open AccessApplication of a Novel Dissolution Medium with Lipids for In Vitro Simulation of the Postprandial Gastric Content
Food can change various physiological parameters along the gastrointestinal tract, potentially impacting postprandial drug absorption. It is thus important to consider different in vivo conditions during in vitro studies. Therefore, a novel dissolution medium simulating variable postprandial pH values and lipid concentrations was developed and used in this study. Additionally, by establishing and validating a suitable analytical method, the effects of these parameters on the dissolution of a model drug, cinnarizine, and on its distribution between the lipid and aqueous phases of the medium were studied. Both parameters, pH value and lipid concentration, were shown to influence cinnarizine behavior in the in vitro dissolution studies. The amount of dissolved drug decreased with increasing pH due to cinnarizine’s decreasing solubility. At pH values 5 and 7, the higher concentration of lipids in the medium increased drug dissolution, and most of the dissolved drug was distributed in the lipid phase. In all media with a lower pH of 3, dissolution was fast and complete, with a significant amount of drug distributed in the lipid phase. These results are in accordance with the in vivo observed positive food effect on cinnarizine bioavailability described in the literature. The developed medium, with its ability to easily adjust the pH level and lipid concentration, thus offers a promising tool for assessing the effect of co-ingested food on the dissolution kinetics of poorly soluble drugs.
- Open Access
- 21 June 2024
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 177, 116969
Exploring the safety of cannabidiol (CBD): A comprehensive in vitro evaluation of the genotoxic and mutagenic potential of a CBD isolate and extract from Cannabis sativa L
- 21 June 2024
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 177, 116969
Open AccessExploring the safety of cannabidiol (CBD): A comprehensive in vitro evaluation of the genotoxic and mutagenic potential of a CBD isolate and extract from Cannabis sativa L
- Open Access
- 30 May 2024
- Published by Walter de Gruyter GmbH in Acta Pharmaceutica
- Vol. 74 (2) , 343-354
Determination of remifentanil in neonatal dried blood spots by liquid chromatography-tandem mass spectrometry
Remifentanil is an ultra-short-acting synthetic opioid-class analgesic which might be increasingly used “off-label” as pain management during labour. Side effects in parturients during labour, and in the infant at birth are of particular concern, especially respiratory depression which is concentration-dependent, and can occur at levels as low as 3–5 ng mL –1 . The safety of such use, particularly in newborns due to remifentanil placental transfer, has not been fully demonstrated yet, partly due to the lack of a suitable non-invasive analytical method. The aim of our work was to develop a sensitive method to monitor the levels of remifentanil in neonates by a non-invasive sampling of umbi lical cord blood to support efficacy and safety trials. The presented LC-MS method is sensitive enough to reliably quantify remifentanil in just 20 µL of blood at only 0.3 ng mL –1 . The dried blood spot sample preparation included solvent extraction with subsequent solid-phase extraction. The method was validated in terms of accuracy, precision, recovery, matrix effect, and stability, and was successfully applied to a small pilot study. The estimated arterial blood concentrations at the time of delivery ranged from 0.2 to 0.3, and up to 0.9 ng mL –1 in neonatal, and maternal samples, respectively.
- 30 May 2024
- Published by Walter de Gruyter GmbH in Acta Pharmaceutica
- Vol. 74 (2) , 343-354
Open AccessDetermination of remifentanil in neonatal dried blood spots by liquid chromatography-tandem mass spectrometry
Remifentanil is an ultra-short-acting synthetic opioid-class analgesic which might be increasingly used “off-label” as pain management during labour. Side effects in parturients during labour, and in the infant at birth are of particular concern, especially respiratory depression which is concentration-dependent, and can occur at levels as low as 3–5 ng mL –1 . The safety of such use, particularly in newborns due to remifentanil placental transfer, has not been fully demonstrated yet, partly due to the lack of a suitable non-invasive analytical method. The aim of our work was to develop a sensitive method to monitor the levels of remifentanil in neonates by a non-invasive sampling of umbi lical cord blood to support efficacy and safety trials. The presented LC-MS method is sensitive enough to reliably quantify remifentanil in just 20 µL of blood at only 0.3 ng mL –1 . The dried blood spot sample preparation included solvent extraction with subsequent solid-phase extraction. The method was validated in terms of accuracy, precision, recovery, matrix effect, and stability, and was successfully applied to a small pilot study. The estimated arterial blood concentrations at the time of delivery ranged from 0.2 to 0.3, and up to 0.9 ng mL –1 in neonatal, and maternal samples, respectively.
- Open Access
- 30 March 2024
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (4) , 449
An LC-MS/MS Method for Quantification of Lamotrigine and Its Main Metabolite in Dried Blood Spots
Background: The antiepileptic drug lamotrigine (LTG) shows high pharmacokinetic variability due to genotype influence and concomitant use of glucuronidation inducers and inhibitors, both of which may be frequently taken by elderly patients. Our goal was to develop a reliable quantification method for lamotrigine and its main glucuronide metabolite lamotrigine-N2-glucuronide (LTG-N2-GLU) in dried blood spots (DBS) to enable routine therapeutic drug monitoring and to identify altered metabolic activity for early detection of drug interactions possibly leading to suboptimal drug response. Results: The analytical method was validated in terms of selectivity, accuracy, precision, matrix effects, haematocrit, blood spot volume influence, and stability. It was applied to a clinical study, and the DBS results were compared to the concentrations determined in plasma samples. A good correlation was established for both analytes in DBS and plasma samples, taking into account the haematocrit and blood cell-to-plasma partition coefficients. It was demonstrated that the method is suitable for the determination of the metabolite-to-parent ratio to reveal the metabolic status of individual patients. Conclusions: The clinical validation performed confirmed that the DBS technique is a reliable alternative for plasma lamotrigine and its glucuronide determination.
- 30 March 2024
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (4) , 449
Open AccessAn LC-MS/MS Method for Quantification of Lamotrigine and Its Main Metabolite in Dried Blood Spots
Background: The antiepileptic drug lamotrigine (LTG) shows high pharmacokinetic variability due to genotype influence and concomitant use of glucuronidation inducers and inhibitors, both of which may be frequently taken by elderly patients. Our goal was to develop a reliable quantification method for lamotrigine and its main glucuronide metabolite lamotrigine-N2-glucuronide (LTG-N2-GLU) in dried blood spots (DBS) to enable routine therapeutic drug monitoring and to identify altered metabolic activity for early detection of drug interactions possibly leading to suboptimal drug response. Results: The analytical method was validated in terms of selectivity, accuracy, precision, matrix effects, haematocrit, blood spot volume influence, and stability. It was applied to a clinical study, and the DBS results were compared to the concentrations determined in plasma samples. A good correlation was established for both analytes in DBS and plasma samples, taking into account the haematocrit and blood cell-to-plasma partition coefficients. It was demonstrated that the method is suitable for the determination of the metabolite-to-parent ratio to reveal the metabolic status of individual patients. Conclusions: The clinical validation performed confirmed that the DBS technique is a reliable alternative for plasma lamotrigine and its glucuronide determination.
- Open Access
- 17 March 2024
- Published by Elsevier in Environment International
- Vol. 186, 108585
Innovative analytical methodologies for characterizing chemical exposure with a view to next-generation risk assessment
- 17 March 2024
- Published by Elsevier in Environment International
- Vol. 186, 108585
Open AccessInnovative analytical methodologies for characterizing chemical exposure with a view to next-generation risk assessment
- Open Access
- 22 September 2023
- Published by Elsevier in Science of The Total Environment
- Vol. 906, 167245
The environmental occurrence, fate, and risks of 25 endocrine disruptors in Slovenian waters
- 22 September 2023
- Published by Elsevier in Science of The Total Environment
- Vol. 906, 167245
Open AccessThe environmental occurrence, fate, and risks of 25 endocrine disruptors in Slovenian waters